Fed Circ says Indivior patent was anticipated

The US Court of Appeals for the Federal Circuit has affirmed a US Patent Trial and Appeal Board (PTAB) decision that held that claims of a patent for dissolvable films containing therapeutic agents were anticipated.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Indivior appeal fails to stop generic opioid addiction challenge

15 July 2019 The US Court of Appeals for the Federal Circuit has upheld an earlier ruling that Indivior cannot stop two competitors from making a generic version of one of its drugs.

Americas

Indivior loses battle over Suboxone generic

22 November 2018 The US Court of Appeals for the Federal Circuit vacated a preliminary injunction against India-based Dr Reddy’s earlier this week, in a blow for addiction treatment drug producer Indivior.

Big Pharma

Indivior parts with $30m in Suboxone dispute

22 August 2023 The pharmaceutical company agreed to pay millions to resolve a multi-district antitrust suit brought by more than 40 US state attorneys | Company sued over alleged actions aimed at preserving the monopoly of anti-addiction drug.

More on this story

Big Pharma

Indivior appeal fails to stop generic opioid addiction challenge

15 July 2019 The US Court of Appeals for the Federal Circuit has upheld an earlier ruling that Indivior cannot stop two competitors from making a generic version of one of its drugs.

Americas

Indivior loses battle over Suboxone generic

Big Pharma

Indivior parts with $30m in Suboxone dispute

More on this story

Big Pharma

Indivior appeal fails to stop generic opioid addiction challenge

15 July 2019 The US Court of Appeals for the Federal Circuit has upheld an earlier ruling that Indivior cannot stop two competitors from making a generic version of one of its drugs.

Americas

Indivior loses battle over Suboxone generic

Big Pharma

Indivior parts with $30m in Suboxone dispute